Vaxcyte, Inc. Insider Trading Activity

Jim Wassil, Chief Operating Officer of Vaxcyte, Inc., reported the sale of 2,250 shares of Common Stock on May 1, 2026. The sales were executed under a Rule 10b5-1 trading plan. The shares were sold at a weighted-average price of $56.831, with individual sales ranging from $56.425 to $57.26. Following the transaction, Wassil holds 160,744 shares of Vaxcyte, Inc. common stock.